Chronic myeloid leukemia patients call for quality and consistency when generics are introduced to treat their cancer

Detalles Bibliográficos
Autores principales: Geissler, J, Sharf, G, Cugurovic, J, Padua, R, Narbutas, Š, Remic, M, Venkatesh, V
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2016
Materias:
Letter to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5155028/
https://www.ncbi.nlm.nih.gov/pubmed/27484147
http://dx.doi.org/10.1038/leu.2016.220
_version_ 1782474929499799552
author Geissler, J
Sharf, G
Cugurovic, J
Padua, R
Narbutas, Š
Remic, M
Venkatesh, V
author_facet Geissler, J
Sharf, G
Cugurovic, J
Padua, R
Narbutas, Š
Remic, M
Venkatesh, V
author_sort Geissler, J
collection PubMed
description
format Online
Article
Text
id pubmed-5155028
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Nature Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-51550282016-12-29 Chronic myeloid leukemia patients call for quality and consistency when generics are introduced to treat their cancer Geissler, J Sharf, G Cugurovic, J Padua, R Narbutas, Š Remic, M Venkatesh, V Leukemia Letter to the Editor Nature Publishing Group 2016-12 2016-08-26 /pmc/articles/PMC5155028/ /pubmed/27484147 http://dx.doi.org/10.1038/leu.2016.220 Text en Copyright © 2016 The Author(s) http://creativecommons.org/licenses/by-nc-sa/4.0/ This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License. The images or other third party material in this article are included in the article's Creative Commons license, unless indicated otherwise in the credit line; if the material is not included under the Creative Commons license, users will need to obtain permission from the license holder to reproduce the material. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/4.0/
spellingShingle Letter to the Editor
Geissler, J
Sharf, G
Cugurovic, J
Padua, R
Narbutas, Š
Remic, M
Venkatesh, V
Chronic myeloid leukemia patients call for quality and consistency when generics are introduced to treat their cancer
title Chronic myeloid leukemia patients call for quality and consistency when generics are introduced to treat their cancer
title_full Chronic myeloid leukemia patients call for quality and consistency when generics are introduced to treat their cancer
title_fullStr Chronic myeloid leukemia patients call for quality and consistency when generics are introduced to treat their cancer
title_full_unstemmed Chronic myeloid leukemia patients call for quality and consistency when generics are introduced to treat their cancer
title_short Chronic myeloid leukemia patients call for quality and consistency when generics are introduced to treat their cancer
title_sort chronic myeloid leukemia patients call for quality and consistency when generics are introduced to treat their cancer
topic Letter to the Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5155028/
https://www.ncbi.nlm.nih.gov/pubmed/27484147
http://dx.doi.org/10.1038/leu.2016.220
work_keys_str_mv AT geisslerj chronicmyeloidleukemiapatientscallforqualityandconsistencywhengenericsareintroducedtotreattheircancer
AT sharfg chronicmyeloidleukemiapatientscallforqualityandconsistencywhengenericsareintroducedtotreattheircancer
AT cugurovicj chronicmyeloidleukemiapatientscallforqualityandconsistencywhengenericsareintroducedtotreattheircancer
AT paduar chronicmyeloidleukemiapatientscallforqualityandconsistencywhengenericsareintroducedtotreattheircancer
AT narbutass chronicmyeloidleukemiapatientscallforqualityandconsistencywhengenericsareintroducedtotreattheircancer
AT remicm chronicmyeloidleukemiapatientscallforqualityandconsistencywhengenericsareintroducedtotreattheircancer
AT venkateshv chronicmyeloidleukemiapatientscallforqualityandconsistencywhengenericsareintroducedtotreattheircancer

Ejemplares similares